News

23andMe Sells DNA Database to Regeneron in £256m Deal: Is Your Data Safe?
Me's sale to Regeneron transfers genetic data for drug development, raising privacy issues and concerns over consumer control ...
23andMe sells its most valuable asset. Regeneron promises keep your DNA private.
Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 ...
23andMe sale reveals what your genetic data is worth. It’s less than you think
The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...
Rolling Out3d
The fall of 23andMe and what it means for your DNA
The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.
Pharmabiz1d
Regeneron Pharmaceuticals enters into asset purchase agreement to acquire 23andMe for $256 million
Regeneron Pharmaceuticals enters into asset purchase agreement to acquire 23andMe for $256 million: Tarrytown, New York Wednesday, May 21, 2025, 13:00 Hrs [IST] Regeneron Pharmace ...
Regeneron Continues To Regenerate Its Drug Pipeline, While Keeping Leverage Down
Regeneron earns a buy rating with strong profit margins, low debt, and growth potential. Discover why shares may see a 39% ...
75th Annual Regeneron International Science and Engineering Fair Awards Teen Scientists from Around the World More Than $9 Million in 2025 Competition
Regeneron Pharmaceuticals, Inc. and Society for Science (the Society) announced that Adam Kovalčík, 19, of Dulovce, Slovakia, ...
Morningstar3d
Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale
Regeneron is shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling it to identify innovative ...